Remove 2025 Remove Competition Remove Physicians
article thumbnail

op Pharma Marketing Trends Shaping the Future of Healthcare in 2025

Pharma Marketing Network

As we approach 2025, the pharmaceutical industry is witnessing a seismic shift in marketing strategies, driven by technological advancements and evolving consumer expectations. Data-driven strategies enable pharma marketers to identify patterns and predict future trends, allowing them to stay ahead of the competition.

article thumbnail

Competition is on the horizon for costly narcolepsy treatments

pharmaphorum

But increased competition is on the horizon. Both the physician and the patient have to be registered and the drugs can only come from a primary source through limited distribution. Competition starts to heat up. The post Competition is on the horizon for costly narcolepsy treatments appeared first on. About the author.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Consequences of the First 10 Drugs Selected for Medicare’s Negotiation Program

PM360

They do not have biosimilar or generic competition available in the market. Additionally, highly competitive classes, such as rapid-acting insulin and immunologics are included on the selected drug list. After this period, CMS will begin to include physician-administered drugs covered under Part B in the program.

article thumbnail

Tips to Boost B2B Medical Sales

Scott’s Directories

There are a few ways to help boost these sales and remain competitive. A good way to get to know clients is through a list of doctors in Canada, which provides details on physicians, nurses, and staff in the medical industry within a given area. billion by the end of 2025, from $196.3 billion in 2017”.

article thumbnail

Pulsed field ablation re-energizes the atrial fibrillation market

Clarivate

Increased appeal for dual-energy systems: Sometimes a situation calls for RF, but physicians like the ease and efficiency of PFA. FDA approval in the fourth quarter, with Johnson & Johnson’s Varipulse system close behind, so competition will pick up. The drop will likely be slower than in cryo, however.

article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

CVS then began affiliating with health systems across the country (like Cleveland Clinic ) for physician oversight of MinuteClinic’s staffed midlevel providers, just as Walgreens was rising as a formidable competitor in the convenient care space through its own walk-in clinics that it launched in fall 2006.

article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

Humana is following a similar growth strategy as it sharpens competition with UnitedHealthcare in the Medicare Advantage sector. Humana is also on track to add 30 to 50 new senior-focused primary-care centers each year through 2025.

Retail 52